152 related articles for article (PubMed ID: 35353437)
1. Therapeutic plasma exchange for optic neuritis attacks in patients with neuromyelitis optica spectrum disorders.
Gonzalez C; Vargas D; Contreras K; Garcia P; Rodriguez P; Zarco L; Navas C
Ther Apher Dial; 2022 Dec; 26(6):1274-1280. PubMed ID: 35353437
[TBL] [Abstract][Full Text] [Related]
2. [Progress in the treatment of neuromyelitis optica spectrum disorders related optic neuritis].
Song HL; Xu QG; Wei SH
Zhonghua Yan Ke Za Zhi; 2020 Jul; 56(7):539-543. PubMed ID: 32842338
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders and Related Disorders in Resource-Limited Settings: Outcomes in a Multiethnic Single-Center Population.
Ong ZM; Schee JP; Viswanathan S
Ther Apher Dial; 2020 Jun; 24(3):312-323. PubMed ID: 31654607
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of therapeutic apheresis in patients with refractory neuromyelitis optica spectrum disorders: a single-center retrospective study.
Zhang L; Zhuang Y; Liu X; Xu Q; Zhou L; Zou L; Jiang Y; Tian J; Yao H; Chi H; Qiu X; Yang T; Wang D; Yu Y
Ann Palliat Med; 2021 Mar; 10(3):3105-3114. PubMed ID: 33752428
[TBL] [Abstract][Full Text] [Related]
5. Clinical Course and Treatment Response of Neuromyelitis Optica Spectrum Disease: An 8-Year Experience.
Lin CW; Lin IH; Chen TC; Jou JR; Woung LC
Asia Pac J Ophthalmol (Phila); 2019; 8(3):206-210. PubMed ID: 30421588
[TBL] [Abstract][Full Text] [Related]
6. Plasma exchange: an effective add-on treatment of optic neuritis in neuromyelitis optica spectrum disorders.
Song W; Qu Y; Huang X
Int Ophthalmol; 2019 Nov; 39(11):2477-2483. PubMed ID: 30825049
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic plasma exchange for neuromyelitis optica spectrum disorder: A multicenter retrospective study by the ASFA neurologic diseases subcommittee.
Ipe TS; Raval JS; Fernando LP; Gokhale A; Jacquot C; Johnson AD; Kim HC; Monis GF; Mo YD; Morgan SM; Pagano MB; Pham HP; Sanford K; Schmidt AE; Schwartz J; Waldman A; Webb J; Winters JL; Wu Y; Yamada C; Wong ECC
J Clin Apher; 2020 Jan; 35(1):25-32. PubMed ID: 31705563
[TBL] [Abstract][Full Text] [Related]
8. Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelination.
Savransky A; Rubstein A; Rios MH; Vergel SL; Velasquez MC; Sierra SP; Marcarian G; Alba R; Pugliese AM; Tenembaum S
Neurology; 2019 Nov; 93(22):e2065-e2073. PubMed ID: 31645471
[TBL] [Abstract][Full Text] [Related]
9. Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review.
Naphattalung Y; Chuenkongkaew WL; Chirapapaisan N; Laowanapiban P; Sawangkul S
Ann Med; 2023 Dec; 55(1):2227422. PubMed ID: 37387119
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
Aungsumart S; Apiwattanakul M
Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
Siritho S; Nopsopon T; Pongpirul K
J Neurol; 2021 Dec; 268(12):4549-4562. PubMed ID: 33037886
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder-related optic neuritis.
Yang Q; Lai C; Meng C; Chang Q; Wei N; Wang J
Neurol Sci; 2024 May; 45(5):2191-2197. PubMed ID: 37982973
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Plasma Exchange in Neuromyelitis Optica Spectrum Disorders-Experience from Tertiary Care Center in North India.
Hans R; Prakash S; Sharma RR; Sankhyan N; Takkar A; Goyal M; Saikia B; Lal V; Marwaha N
Neurol India; 2022; 70(2):710-713. PubMed ID: 35532644
[TBL] [Abstract][Full Text] [Related]
14. Protein spectrum changes in exosomes after therapeutic plasma exchange in patients with neuromyelitis optica.
Ma C; Wang S; Wang G; Wu Y; Yang T; Shen W; Zhuang Y; Zhang L; Liu X; Yang L; Feng Y; Yu Y; Liu Z; Wang D
J Clin Apher; 2020 Jun; 35(3):206-216. PubMed ID: 32240559
[TBL] [Abstract][Full Text] [Related]
15. Short-term effect of additional apheresis on visual acuity changes in patients with steroid-resistant optic neuritis in neuromyelitis optica spectrum disorders.
Mori S; Kurimoto T; Ueda K; Nakamura M
Jpn J Ophthalmol; 2018 Jul; 62(4):525-530. PubMed ID: 29802557
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma exchange for neuromyelitis optica attacks: Evidence and challenges from a real-world cohort from Brazil.
de Almeida GMR; de Araujo RS; Castrillo BB; Silva GD; Fortini I; Gonçalves MRR; Castro LHM; Tatsui NH; Adoni T; Sato DK; Apóstolos-Pereira SL; Callegaro D
J Neuroimmunol; 2024 Mar; 388():578295. PubMed ID: 38280268
[TBL] [Abstract][Full Text] [Related]
17. Visual Outcomes Following Plasma Exchange for Optic Neuritis: An International Multicenter Retrospective Analysis of 395 Optic Neuritis Attacks.
Chen JJ; Flanagan EP; Pittock SJ; Stern NC; Tisavipat N; Bhatti MT; Chodnicki KD; Tajfirouz DA; Jamali S; Kunchok A; Eggenberger ER; Nome MAD; Sotirchos ES; Vasileiou ES; Henderson AD; Arnold AC; Bonelli L; Moss HE; Navarro SEV; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Wilf-Yarkoni A; Danesh-Meyer H; Ivanov S; Huda S; Forcadela M; Hodge D; Poullin P; Rode J; Papeix C; Saheb S; Boudot de la Motte M; Vignal C; Hacohen Y; Pique J; Maillart E; Deschamps R; Audoin B; Marignier R
Am J Ophthalmol; 2023 Aug; 252():213-224. PubMed ID: 36822570
[TBL] [Abstract][Full Text] [Related]
18. Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders.
Bonnan M; Valentino R; Debeugny S; Merle H; Fergé JL; Mehdaoui H; Cabre P
J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):346-351. PubMed ID: 29030418
[TBL] [Abstract][Full Text] [Related]
19. Sequential intermittent therapeutic plasma exchange: A possible induction and maintenance therapy in the management of adult patients with neuromyelitis optica spectrum disorder.
Viswanathan S; Schee JP; Omar MA; Hiew FL
Ther Apher Dial; 2021 Aug; 25(4):513-532. PubMed ID: 33029928
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based management of optic neuritis.
Bergeron E; Bouffard MA
Curr Opin Ophthalmol; 2024 Jan; 35(1):73-82. PubMed ID: 37846574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
